Simplex Trading, LLC Cyclacel Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$0.52 - $0.76 $477 - $698	-919 Reduced 98.18%	17 $0
Q1 2023 Apr 27, 2023	SELL	$0.56 - $1.15 $573 - $1,177	-1,024 Reduced 52.24%	936 $0
Q4 2022 Feb 02, 2023	SELL	$0.54 - $21.75 $15,390 - $619,875	-28,500 Reduced 93.57%	1,960 $1,000
Q3 2022 Nov 04, 2022	SELL	$1.23 - $21.9 $1,339 - $23,849	-1,089 Reduced 3.45%	30,460 $44,000
Q2 2022 Aug 03, 2022	BUY	$6.1 - $7.15 $174,960 - $205,076	28,682 Added 1000.42%	31,549 $34,000
Q1 2022 May 02, 2022	SELL	$5.93 - $7.6 $32,537 - $41,701	-5,487 Reduced 65.68%	2,867 $8,000
Q4 2021 Feb 23, 2022	BUY	$6.04 - $8.03 $50,458 - $67,082	8,354 New	8,354 $32,000

Ticker CYCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,539,200
Market Cap $6.02M
Description
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.